(Q42906338)

10 November 2017

title

GIP: no longer the neglected incretin twin? (English)

1 reference

10 November 2017

GIP: No Longer the Neglected Incretin Twin? (English)

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.3001027

14 July 2024

author name string

Rohit N. Kulkarni

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20844284

14 July 2024

language of work or name

English

0 references

publication date

1 September 2010

1 reference

10 November 2017

15 September 2010

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20844284

full work available at URL

14 July 2024

https://www.science.org/doi/pdf/10.1126/scitranslmed.3001027

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.3001027

Science Translational Medicine

14 July 2024

published in

1 reference

10 November 2017

volume

2

1 reference

10 November 2017

issue

49

1 reference

10 November 2017

page(s)

49ps47

1 reference

Post-challenge hyperglycaemia is associated with premature death and macrovascular complications

10 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

Glucose intolerance and reduced proliferation of pancreatic beta-cells in transgenic pigs with impaired glucose-dependent insulinotropic polypeptide function

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

Glucagon-like peptide-1 is a physiological incretin in rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

Glucagon-like peptide-1 7-36: a physiological incretin in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

Physiology of incretins (GIP and GLP-1) and abnormalities in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

The role of gut hormones in glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

Discovery of amino acid variants in the human glucose-dependent insulinotropic polypeptide (GIP) receptor: the impact on the pancreatic beta cell responses and functional expression studies in Chinese hamster fibroblast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

Genomewide association studies and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

A GIP receptor agonist exhibits beta-cell anti-apoptotic actions in rat models of diabetes resulting in improved beta-cell function and glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

Insulin action in the double incretin receptor knockout mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

Double incretin receptor knockout (DIRKO) mice reveal an essential role for the enteroinsular axis in transducing the glucoregulatory actions of DPP-IV inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

Growth factor control of pancreatic islet regeneration and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

Glucagon-like peptide-1 increases beta-cell glucose competence and proliferation by translational induction of insulin-like growth factor-1 receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

Exendin-4 uses Irs2 signaling to mediate pancreatic beta cell growth and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

Glucose-dependent insulinotropic polypeptide (GIP) stimulation of pancreatic beta-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxo1, and dow

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

The pseudokinase tribbles homolog 3 interacts with ATF4 to negatively regulate insulin exocytosis in human and mouse beta cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

Therapeutic potential of aleglitazar, a new dual PPAR-α/γ agonist: implications for cardiovascular disease in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

Dual endothelin receptor antagonism prevents remodeling of resistance arteries in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

Xenin-25 potentiates glucose-dependent insulinotropic polypeptide action via a novel cholinergic relay mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

Glucose-dependent insulinotropic polypeptide (Gastric Inhibitory Polypeptide; GIP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

Therapeutic potential for GIP receptor agonists and antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

GIP increases human adipocyte LPL expression through CREB and TORC2-mediated trans-activation of the LPL gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

Inhibition of gastric inhibitory polypeptide signaling prevents obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

GIP as a potential therapeutic agent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

Transgenerational genetic effects on phenotypic variation and disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

Missing heritability and strategies for finding the underlying causes of complex disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

RNA induction and inheritance of epigenetic cardiac hypertrophy in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

Trans-generational epistasis between Dnd1Ter and other modifier genes controls susceptibility to testicular germ cell tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001027

NEW INTERPRETATION OF ORAL GLUCOSE TOLERANCE

21 January 2018

4

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.3001027

Identification and Actions of Gastric Inhibitory Polypeptide

14 July 2024

7

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.3001027

Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses

14 July 2024

13

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.3001027

14 July 2024

Identifiers

1 reference

10 November 2017

1 reference